SERA PROGNOSTICS, INC. Uncategorized Contracts & Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2, dated December 6, 2023, to Side Letter with Baker Bros. Advisors LP, dated as of April 29, 2021, by and between Baker Bros. Advisors LP and the Registrant
SERA PROGNOSTICS, INC.
Biotechnology
2024
Amendment No. 1, dated February 16, 2023, to Side Letter with Baker Bros. Advisors LP, dated as of April 29, 2021, by and between Baker Bros. Advisors LP and the Registrant
SERA PROGNOSTICS, INC.
Biotechnology
2023
Description of Securities
SERA PROGNOSTICS, INC.
Biotechnology
2022
Offer Letter by and between the Registrant and Nichole Martin, dated March 30, 2020
SERA PROGNOSTICS, INC.
Biotechnology
2021
Third Amendment to Offer Letter by and between the Registrant and Thomas Garite, dated April 28, 2021
SERA PROGNOSTICS, INC.
Biotechnology
2021
Second Amendment to Offer Letter by and between the Registrant and Thomas Garite, dated July 30, 2020
SERA PROGNOSTICS, INC.
Biotechnology
2021
Amendment to Offer Letter by and between the Registrant and Thomas Garite, dated July 1, 2020
SERA PROGNOSTICS, INC.
Biotechnology
2021
Offer Letter by and between the Registrant and Thomas Garite, dated June 17, 2020
SERA PROGNOSTICS, INC.
Biotechnology
2021
Offer Letter by and between the Registrant and John Peltier, dated July 8, 2016
SERA PROGNOSTICS, INC.
Biotechnology
2021
Side Letter with Baker Bros. Advisors LP, dated as of April 29, 2021, by and between Baker Bros. Advisors LP and the Registrant
SERA PROGNOSTICS, INC.
Biotechnology
DE
2021
Second Amendment to the Commercialization Agreement, dated as of January 25, 2021, by and between Laboratory Corporation of America Holdings and the Registrant
SERA PROGNOSTICS, INC.
Biotechnology
2021
First Amendment to the Commercialization Agreement, dated as of June 25, 2018, by and between Laboratory Corporation of America Holdings and the Registrant
SERA PROGNOSTICS, INC.
Biotechnology
2021
Commercialization Agreement, dated as of January 9, 2017, by and between Laboratory Corporation of America Holdings and the Registrant
SERA PROGNOSTICS, INC.
Biotechnology
DE
2021